Search Medical Condition
Please enter condition
Please choose location

Emphysema Clinical Trials

A listing of Emphysema medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (39) clinical trials

If you’re a current or former smoker with COPD (also known as emphysema or chronic bronchitis), you know how challenging this disease can be. Peninsula Research Associates is conducting a new, no-cost clinical research study testing an investigational study medication for COPD. By participating, you’ll receive at no cost: Study-related ...

Phase

Chronic obstructive pulmonary disease (COPD) is a disease of the lungs where the normal airflow of breathing is obstructed or blocked COPD usually gets worse over time and is often caused by long-term exposure irritants, such as cigarette smoke, secondhand smoke, air pollution or chemical fumes. Exposure to these irritants ...

Phase N/A

The ASCENT Study is a clinical research study evaluating a medication for patients diagnosed with COPD who also have a history of heart disease, stroke or other cardiovascular risk factors.

Phase

A Randomized, Double-Blind, Multi-Center, Parallel Group Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 on COPD Exacerbations over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD. ClinicalTrials.gov identifier: NCT02465567 https://www.pearltherapeutics.com/pipeline-overview Study Flyer

Phase N/A

A Randomized, Double-Blind, Multi-Center, Parallel Group Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 on COPD Exacerbations over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD. ClinicalTrials.gov identifier: NCT02465567 https://www.pearltherapeutics.com/pipeline-overview

Phase N/A

A research study comparing Spiriva to a generic investigational medication like Spiriva to placebo.

Phase N/A

An investigational study comparing Spiriva to an investigational nebulized medication with NO Chance of placebo

Phase N/A

The Clinical Research Center is conducting a placebo controlled study to evaluate an investigational medication for COPD. The study medication is a bio-equivalent medication to Spiriva. Your participation in the study could last up to 26 weeks and consist of up to 8 visits.

Phase N/A

The Clinical Research Center is conducting a clinical trial to investigate an investigational medication for COPD. The Study consists of 9 visits over approximately 7 months. The investigational medication will be given by inhaler.

Phase N/A

The Clinical Research Center in West St. Louis County is evaluating the safety and efficacy of an investigational medication for COPD. The study consists of 6 office visits over approximately 22 weeks. The study medication will be delivered by inhaler.

Phase N/A